Top Story

InSite quarterly revenue increases due to Nicox license agreement payment

May 29, 2015

InSite Vision reported $3.4 million in revenues in the first quarter 2015, an increase from $1.2 million in the first quarter of the previous year, according to a press release.

The increase was attributed to a $3 million payment from a license agreement with Nicox to develop and commercialize AzaSite (1% azithromycin), AzaSite Xtra (2% azithromycin) and BromSite (0.075% bromfenac) in Europe, the Middle East and Africa, the release said.

VIDEO: Iris claw AC IOL may be preferred over angle-supported IOLs in pediatric cataract cases Meeting News CoverageVideo

VIDEO: Iris claw AC IOL may be preferred over angle-supported IOLs in pediatric cataract cases

May 29, 2015
KIAWAH ISLAND, S.C. — At the Kiawah Eye 2015 meeting here, Reid Turner, MD, discusses a study examining the safety of angle-supported anterior chamber IOLs and iris…
VIDEO: Scheimpflug lens densitometry an objective measure of lens opacity Meeting News CoverageVideo

VIDEO: Scheimpflug lens densitometry an objective measure of lens opacity

May 29, 2015
KIAWAH ISLAND, S.C. — At the Kiawah Eye 2015 meeting here, David Tremblay, MD, an ophthalmology resident at Storm Eye Institute, discusses a study attempting to use…
Breaking News

AAO airs concerns about beyond-use dates for repackaged Avastin

May 28, 2015
The American Academy of Ophthalmology has provided comments to the FDA expressing its concern that beyond-use dates for repackaged Avastin may limit the drug’s…
Business News

Iridex reports revenues of $10.8 million in first quarter

May 28, 2015
Iridex reported $10.8 million in revenues in the first quarter 2015, a 5% increase from $10.3 million in the first quarter 2014, according to a press release.Net income…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

With anti-VEGF therapy well-established as front-line therapy in the management of age-related macular degeneration and…
More »
Meeting News Coverage Video
VIDEO: Scheimpflug lens densitometry an objective measure of lens opacity

VIDEO: Scheimpflug lens densitometry an objective measure of lens opacity

May 29, 2015
KIAWAH ISLAND, S.C. — At the Kiawah Eye 2015 meeting here, David Tremblay, MD, an ophthalmology resident at Storm Eye…
More »
morganatic-roan